financetom
Business
financetom
/
Business
/
Cantaloupe Buys SB Software
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cantaloupe Buys SB Software
Sep 9, 2024 8:11 AM

09:26 AM EDT, 09/09/2024 (MT Newswires) -- Cantaloupe (CTLP) said Monday it has acquired SB Software, which provides vending and coffee management software services in the UK and Ireland.

Financial details of the deal were not provided.

The acquisition is expected to enhance Cantaloupe's operational capabilities and market reach throughout Europe.

Price: 6.45, Change: +0.15, Percent Change: +2.35

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Uniqure Insider Sold Shares Worth $1,177,517, According to a Recent SEC Filing
Uniqure Insider Sold Shares Worth $1,177,517, According to a Recent SEC Filing
Nov 6, 2025
05:08 PM EST, 11/06/2025 (MT Newswires) -- Jack Kaye, Director, on November 04, 2025, sold 38,810 shares in Uniqure ( QURE ) for $1,177,517. Following the Form 4 filing with the SEC, Kaye has control over a total of 20,439 ordinary shares of the company, with 20,439 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1590560/000090445425000560/xslF345X05/edgar.xml ...
Joint Q3 revenue slightly beats expectations
Joint Q3 revenue slightly beats expectations
Nov 6, 2025
Overview * Joint Q3 revenue grows 6% to $13.4 mln, slightly beating analyst expectations * Net income improves to $855,000 from a loss of $3.2 mln in Q3 2024 * Board authorizes additional $12 mln for share repurchases Outlook * Company updates 2025 system-wide sales guidance to $530 mln-$534 mln from $530 mln-$550 mln * Comp sales now expected to...
Medical devices firm Sensus Healthcare Q3 revenue beats estimates on higher FDA treatment volumes
Medical devices firm Sensus Healthcare Q3 revenue beats estimates on higher FDA treatment volumes
Nov 6, 2025
Overview * Sensus Healthcare Q3 2025 revenue of $6.9 mln beats analyst expectations * Net loss for Q3 2025 was $0.9 mln, reflecting operational challenges * Adjusted EBITDA for Q3 2025 missed analyst estimates Outlook * Company sees strong interest internationally following MDSAP certification * CMS coding expected to strengthen SRT adoption and reimbursement certainty Result Drivers * INCREASED TREATMENT...
Akamai Q3 Adjusted Earnings, Revenue Rise; Updates Guidance
Akamai Q3 Adjusted Earnings, Revenue Rise; Updates Guidance
Nov 6, 2025
05:08 PM EST, 11/06/2025 (MT Newswires) -- Akamai Technologies ( AKAM ) reported Q3 adjusted earnings late Thursday of $1.86 per diluted share, up from $1.59 a year ago. Analysts polled by FactSet expected $1.64. Revenue for the three months ended Sept. 30 was $1.055 billion, up from $1.00 billion a year earlier. Analysts surveyed by FactSet expected $1.04 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved